These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 677139)

  • 1. Cephalosporins: use review and cost analysis.
    Noel MW; Paxinos J
    Am J Hosp Pharm; 1978 Aug; 35(8):933-5. PubMed ID: 677139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Savings achieved through cephalosporin surveillance.
    Katz E; Schlamowitz S
    Am J Hosp Pharm; 1978 Dec; 35(12):1521-3. PubMed ID: 717407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost containment through restriction of cephalosporins.
    Britton HL; Schwinghammer TL; Romano MJ
    Am J Hosp Pharm; 1981 Dec; 38(12):1897-900. PubMed ID: 7325168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost savings achieved through cephalosporin use review and restriction.
    Dzierba SH; Reilly RT; Caselnova DA
    Am J Hosp Pharm; 1986 Sep; 43(9):2194-7. PubMed ID: 3766571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacist impact on parenteral cephalosporin prescribing.
    Lawlor MC; Lucarotti RL
    Hosp Formul; 1983 Apr; 18(4):402-4, 407-8. PubMed ID: 10259512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug usage review and inventory analysis in promoting rational parenteral cephalosporin therapy.
    Simon WA; Thompson L; Campbell S; Lantos RL
    Am J Hosp Pharm; 1975 Nov; 32(11):1116-21. PubMed ID: 1190230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing physician prescribing habits through a cost-effective first generation cephalosporin formulary.
    Cramer R; Wright C
    Hosp Pharm; 1989 Jan; 24(1):33-8. PubMed ID: 10312858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surveillance of cephalosporins therapy in therapeutic practice of 15 Italian hospitals (author's transl)].
    Martini N; Bozzini L
    Quad Sclavo Diagn; 1979 Jun; 15 Suppl 1():406-18. PubMed ID: 555525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of education on cephalosporin prescribing patterns.
    Frye CB; Baker B; Sexton DJ; Dougherty FK
    J Okla State Med Assoc; 1987 Sep; 80(9):649-53. PubMed ID: 3668708
    [No Abstract]   [Full Text] [Related]  

  • 10. Influencing drug use through prescribing restrictions.
    Huber SL; Patry RA; Hudson HD
    Am J Hosp Pharm; 1982 Nov; 39(11):1898-901. PubMed ID: 6128922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use, misuse, and cost of parenteral cephalosporins at a county hospital.
    Appleby DH; John JF
    South Med J; 1980 Nov; 73(11):1473-5. PubMed ID: 7444511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable cost per dose of preparing and administering small-volume cephalosporin admixtures. Veterans Administration Pharmacy Service Study Group.
    Am J Hosp Pharm; 1984 Dec; 41(12):2624-34. PubMed ID: 6517086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achieving parenteral nutrition cost savings through prescribing guidelines and formulary restrictions.
    Maswoswe JJ; Newcomer DR; Quandt CM
    Am J Hosp Pharm; 1987 Jun; 44(6):1376-81. PubMed ID: 3113237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of clinical pharmacists to cefazolin utilization.
    Witte KW; Hatoum HT; Hoon TJ
    Hosp Formul; 1987 Aug; 22(8):737-41. PubMed ID: 10283405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulary evaluation of third-generation cephalosporins using decision analysis.
    Cano SB; Fujita NK
    Am J Hosp Pharm; 1988 Mar; 45(3):566-9. PubMed ID: 3285673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlling moxalactam and cefotaxime use with a target drug program.
    Abramowitz PW; Ludwig DJ; Mansur JM; Nold EG
    Hosp Pharm; 1983 Aug; 18(8):416-20. PubMed ID: 10261791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacy and therapeutics committee review of the parenteral cephalosporins.
    Phelps MR; Godwin HN
    Am J Hosp Pharm; 1978 Jan; 35(1):73-5. PubMed ID: 623122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A standardized parenteral nutrition solution: prescribing, use, processing, and material cost implications.
    Petros WP; Shank WA
    Hosp Pharm; 1986 Jul; 21(7):648-9, 654-6. PubMed ID: 10311603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods of controlling cephalosporin use in Canadian hospitals.
    Godin JP; Sketris IS; Merrett RA; Marrie TJ
    Can J Hosp Pharm; 1988 Apr; 41(2):73-4, 83-4, 96. PubMed ID: 10287052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible savings with appropriate antibiotic prophylaxis.
    Hodgson T; Lannigan R; Mills D
    Can J Hosp Pharm; 1984; 37(3):95-7. PubMed ID: 10268247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.